Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Abstral 100mcg Sublingual Tablet – PA2288/004/002
- Abstral 200mcg Sublingual Tablet – PA2288/004/003
- Abstral 300mcg Sublingual Tablet – PA2288/004/004
- Abstral 400mcg Sublingual Tablet – PA2288/004/005
- Abstral 600mcg Sublingual Tablet – PA2288/004/006
- Abstral 800mcg Sublingual Tablet – PA2288/004/007
- Anapen 150mcg Solution for Injection in Pre-filled Syringe – PA22580/001/001
- Estradot 50mcg Transdermal Patch – PA0896/010/002
- Estradot 75mcg Transdermal Patch – PA0896/010/003
- Inspra 50mg Tablet – PA0822/020/002
- Livial 2.5mg Tablet – PA1286/059/001
- Spectrila 10,000IU Powder and solvent for Solution for Infusion/Injection – EU/1/15/1072/001-002
- Telfast 180mg Film Coated Tablet – PA0540/078/003
- Yasmin 0.03mg/3mg Film Coated Tablet – PA1410/023/001
The following shortage has been resolved and supply has resumed to the Irish market:
- Evorel 50mcg Transdermal Patch – PA22668/008/001
- Evorel Conti 50mcg/170mcg Transdermal Patch – PA22668/009/001
- Levofloxacin 250mg Tablet – PA1347/048/001
- Levofloxacin 500mg Tablet – PA1347/048/002
- Nimbex 2mg/ml Solution for Injection/Infusion – PA1691/030/001
- Sumatriptan 100mg Film Coated Tablet – PA2315/070/002
- Zolmitriptan 2.5mg Orodispersible Tablet – PA1380/035/003
Please see the shortages section of the HPRA website for further information.
The HPRA will be sending weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.